Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize

Details for Australian Patent Application No. 2004258200 (hide)

Owner Monsanto Technology, LLC

Inventors Zheng, Wei; Savidge, Beth

Agent EF WELLINGTON & CO

Pub. Number AU-A-2004258200

PCT Pub. Number WO2005/007829

Priority 60/486,935 14.07.03 US; 10/890,629 14.07.04 US

Filing date 14 July 2004

Wipo publication date 27 January 2005

International Classifications

C12N 15/29 (2006.01) Mutation or genetic engineering - Genes encoding plant proteins, e.g. thaumatin

C12N 5/04 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Plant cells or tissues

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/007829 Priority application(s): WO2005/007829

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004258203-Method for increasing capacity in an automatic clinical analyzer by using modular reagent delivery means

2004258193-Annealing single crystal chemical vapor deposition diamonds